Common Contracts

3 similar Underwriting Agreement contracts by Humana Inc

HUMANA INC. $250,000,000 5.375% Senior Notes due 2031 UNDERWRITING AGREEMENT
Underwriting Agreement • March 31st, 2025 • Humana Inc • Hospital & medical service plans • New York

Humana Inc., a Delaware corporation (the “Company”), proposes to sell $250,000,000 aggregate principal amount of the Company’s 5.375% Senior Notes due 2031 (the “Additional Notes”). The Additional Notes offered hereby will be an additional issuance of the 5.375% Senior Notes due 2031 that were issued in an aggregate principal amount of $1,250,000,000 on March 13, 2024 (referred to herein as the “Existing 2031 Notes” and, where the context requires, together with the Additional Notes, referred to herein as the “Notes”). The Additional Notes are to be issued pursuant to an Indenture, dated as of August 5, 2003 (the “Base Indenture”), as supplemented by the Twenty-Eighth Supplemental Indenture, dated as of March 13, 2024 (the “2031 Notes Supplemental Indenture”; the Base Indenture, as supplemented by the 2031 Notes Supplemental Indenture, the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (

HUMANA INC. UNDERWRITING AGREEMENT
Underwriting Agreement • June 3rd, 2008 • Humana Inc • Hospital & medical service plans • New York

Humana Inc., a Delaware corporation (the “Company”), proposes to sell (i) $500,000,000 in aggregate principal amount of the Company’s 7.20% Senior Notes due 2018 (the “Ten-Year Notes”) and (ii) $250,000,000 in aggregate principal amount of the Company’s 8.15% Senior Notes due 2038 (the “Thirty-Year Notes” and, together with the Ten-Year Notes, the “Notes”). The Ten-Year Notes are to be issued pursuant to an Indenture, dated as of August 5, 2003 (the “Base Indenture”), as supplemented by the Third Supplemental Indenture, to be dated as of June 5, 2008 (the “Ten-Year Notes Supplemental Indenture”; the Base Indenture, as supplemented by the Ten-Year Notes Supplemental Indenture, the “Ten-Year Notes Indenture”), to be entered into between the Company and The Bank of New York Trust Company, N.A. (as successor to The Bank of New York), as trustee (the “Trustee”), and the Thirty-Year Notes are to be issued pursuant to the Base Indenture, as supplemented by the Fourth Supplemental Indenture, t

HUMANA INC. UNDERWRITING AGREEMENT
Underwriting Agreement • May 26th, 2006 • Humana Inc • Hospital & medical service plans • New York

Humana Inc., a Delaware corporation (the “Company”), proposes to sell $500,000,000 in aggregate principal amount of the Company’s 6.450% Senior Notes due 2016 (the “Notes”). The Notes are to be issued pursuant to an Indenture, dated as of August 5, 2003 (the “Base Indenture”), as supplemented by the Second Supplemental Indenture, to be dated as of May 31, 2006 (the “Supplemental Indenture”; the Base Indenture, as supplemented by the Supplemental Indenture, the “Indenture”), to be entered into between the Company and The Bank of New York Trust Company, N.A. (as successor to The Bank of New York), as trustee (the “Trustee”). This is to confirm the agreement concerning the purchase of the Notes from the Company by the Underwriters named in Schedule 1 hereto (the “Underwriters”).